Rho kinase inhibitors for SARS-CoV-2 induced acute respiratory distress syndrome: Support from Bartter's and Gitelman's syndrome patients

Pharmacol Res. 2020 Aug:158:104903. doi: 10.1016/j.phrs.2020.104903. Epub 2020 May 13.

Authors

Lorenzo A Calò¹, Giovanni Bertoldi², Paul A Davis³

Affiliations

¹ Nephrology, Dialysis and Transplantation Unit, Department of Medicine, University of Padova, Italy. Electronic address: renzcalo@unipd.it.
² Nephrology, Dialysis and Transplantation Unit, Department of Medicine, University of Padova, Italy.
³ Department of Nutrition, University of California, Davis, USA.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Acute Lung Injury*
Betacoronavirus
COVID-19
Coronavirus Infections*
Gitelman Syndrome*
Humans
Pandemics*
Pneumonia, Viral*
Respiratory Distress Syndrome*
SARS-CoV-2
rho-Associated Kinases

Substances

rho-Associated Kinases